Ferrer, Poirot & Wansbrough | Injury Law Blog
November 24th, 2015
More than 20 million Americans have Type 2 diabetes, a condition in which the body cannot regulate blood sugar levels. Medications can treat the disease, but the drug injury lawyers at Ferrer, Poirot & Wansbrough point out that patients should be aware that some of these drugs may cause serious side effects.
Januvia® and Janumet® are just a few of the drugs linked to health problems in diabetic patients. Studies have shown these medications may increased the risk of pancreatic cancer and acute pancreatitis. Both conditions can be difficult to treat and may require costly surgery or treatment.
Earlier this year, the U.S. Food and Drug Administration issued warnings regarding another condition these drugs may cause. The agency stated Januvia and Janumet may play a role in some patients developing severe and disabling joint pain. Since the announcement, the agency has required the manufacturers of the drugs to update warning labels on the drugs.
If you’ve suffered a diabetes drug injury, you likely have many questions regarding your legal rights. That’s why we urge you to visit our website to learn more about the options available to you.
November 17th, 2015
Drug manufacturer, Johnson & Johnson, has come under fire for failing to warn patients about the risks associated with their medication, Risperdal®. Now, the company has been ordered to pay millions of dollars to one patient who suffered adverse health effects as a result of taking the drug.
In 2004, Risperdal® was approved to treat a variety of mental disorders in adult patients. However, the maker of the drug began to market the medication to children shortly thereafter.
The results were that many young patients developed Gynecomastia—a condition in which males develop excessive amounts of breast tissue that can require corrective surgery. Many of the victims of Risperdal® side effects have now successfully filed lawsuits against Johnson & Johnson claiming they were not warned of the risks associated with the drug.
Court documents show Johnson & Johnson has been ordered to pay $1.8 million to a 21-year-old Maryland man who developed Gynecomastia as a result of using Risperdal®. A report from Bloomberg News says this is the third verdict to come in favor of those who have lawsuits after suffering adverse side effects from taking Risperdal®. A filing with the U.S. Securities and Exchange Commission indicates the company could be facing as many as 5,400 similar suits in the future.
Taking legal action can be an effective way for citizens to hold drug manufacturers accountable for their products. The legal staff at Ferrer, Poirot & Wansbrough is hopeful the drug injury lawsuits and settlements that have been filed in connection to Risperdal® and Gynecomastia will bring closure to those who have been harmed.
November 10th, 2015
In 1987, the Bair Hugger™ forced air warming blanket was introduced to keep patients warm while undergoing surgical procedures. Since that time, the device has been used by more than 200 million people. However, patients may not realize the device may be threatening their health.
The Bair Hugger works by blowing warmed air through the blanket. But the device’s blower can release air that contains dangerous pathogens onto the patient’s wounds or incisions. This can result in deep tissue infections.
Some of those infected after using the Bair Hugger system filed Bair Hugger hospital infection lawsuits. The victims claim the maker of the device was aware of the risks it posed, yet took no corrective action to protect the public from harm.
In 2010, the inventor of the Bair Hugger blanket told the The New York Times about the potential dangers his device posed. Yet, 3M, the device’s manufacturer, continued production despite being aware of the risks it posed. An article from Outpatient Surgery explains that 3M has denied the claims are true.
At Ferrer, Poirot & Wansbrough, we recognize the serious harm that a defective medical device can cause, and our legal staff is hopeful the outcome of the Bair Hugger injury lawsuits will help protect the health and safety of those undergoing all types of medical procedures.
November 3rd, 2015
Companies that manufacture medications are required to thoroughly test their product to help reduce the risk of serious drug injuries. But sometimes, dangerous drugs are released to patients.
The U.S. Food and Drug Administration (FDA) recently issued warnings about the serious risks related to two different Hepatitis C drugs. Officials linked used of the medications to serious liver damage in some patients.
Viekira Pak and Technivie were both approved to treat the symptoms of the viral disease in Dec. 2014. Since that time, the FDA has received 26 reports of patients suffering serious liver damage. The Washington Post reports some patients died as the result of their injuries, while others had to undergo corrective treatments and procedures—including liver transplants.
The FDA is encouraging users to be on the lookout for signs of liver damage, such as loss of appetite, fatigue, nausea, vomiting, and yellowing of the skin or eyes. Patients are also being urged to continue using the medications unless instructed otherwise by your physician.
If you’ve been harmed as the result of taking either Viekira Pak or Technivie, it’s important to know you may have a drug injury lawsuit. Learn more about the options and resources available to drug injury victims by visiting our website.
October 27th, 2015
Workout supplements can be an effective way to enhance your athletic performance. However, consuming these types of products can also present serious health risks.
For instance, products containing a substance called dimethylamylamine (DMAA), otherwise known geranium extract, can present users with workout supplement health risks, such as adverse cardiac events and organ failure. Use of products containing DMAA has been linked to at least two deaths and several other serious injuries.
The U.S. Food and Drug Administration ordered products containing DMAA off the market several years ago, but new research shows this dangerous chemical is still found in many workout supplements available online today.
According to USA Today, investigators with the Defense Department’s Human Performance Resource Center found nearly 40 supplements containing DMAA that could be purchased online by Americans. A company based in Georgia, Hi-Tech Pharmaceuticals, made roughly 25 percent of those products.
Officials are warning consumers of workout supplements to thoroughly check the labels on products to ensure they are safe and free of DMAA.
Protecting the health and safety of all citizens is just one of the goals at Ferrer, Poirot & Wansbrough. That’s why our drug injury lawyers are here to help if you’ve been seriously harmed as the result of using a workout supplement that contained DMAA. We’re available to speak with you about your questions and case anytime by calling (866) 589-0257.
October 20th, 2015
Power morcellators are medical devices that can perform hysterectomies and other medical procedures in a less invasive manner than traditional surgical methods. However, the device lost credibility when it was discovered it can significantly increase the chances of developing cancer in some women.
Researchers found that when the morcellator is used, dormant cancerous cells can be released into the body, where they can later metastasize into tumors. Data from the U.S. Food and Drug Administration shows at least 1-in-350 women are at an increased risk of developing power morcellator cancer when the devices are used.
These discoveries have led to hundreds of lawsuits being filed against the makers of the devices, claiming victims were not warned of the risks before undergoing a power morcellator surgery. Now, these cases are being consolidated into multidistrict litigation.
According to KCUR 98.3 Radio, more than two dozen power morcellator cancer lawsuits—a majority of which are filed against device manufacturer Ethicon— have been moved to a Kansas City, Kansas, federal court to be heard. U.S. District Judge, Kathryn H. Vratil, has been assigned to preside over the case.
The legal staff at Ferrer, Poirot & Wansbrough believe in holding companies accountable for the safety of the products they make. That’s why our defective medical device lawyers are hopeful a decision in the cases will bring a sense of closure to individuals harmed by morcellators.
October 13th, 2015
A man’s sex drive, muscle mass, and energy can decrease as he ages due to a decrease in a hormone called testosterone. Many men undergo hormone replacement therapy to ward off these symptoms of aging. However, the drug injury attorneys at Ferrer, Poirot & Wansbrough explain that such treatments can put men at an increased risk of suffering adverse cardiac events.
Testosterone therapy heart attacks came to light when reports began to surface that men were suffering cardiac events after beginning testosterone therapy drugs. These reports prompted a team of researchers from Harvard Medical School to study the potential risks. They found the chances of an older male having a heart attack or stroke while undergoing testosterone therapy can be as much as 30 times higher than that of a man not taking these medications. This is because testosterone can cause an overproduction of red blood cells, which can lead to the development of blood clots.
These findings have led to a number of lawsuits against the makers of testosterone replacement medications. Now, according to CBS News, a large number of those cases will soon be heard in Chicago.
At Ferrer, Poirot & Wansbrough, we recognize the struggles many men undergoing testosterone therapy have faced along their journey to recovery. That’s why our drug injury attorneys are hopeful a decision in these cases will help bring a sense of closure to the victims in these matters.
October 6th, 2015
Companies that manufacture medical devices are required by law to ensure the safety and proper function of their products. However, an investigation has shown that C.R. Bard, Inc.—a medical device manufacturer—may have known about risks that its Inferior Vena Cava (IVC) filter posed to patients without taking corrective action.
An IVC filter is a small spider-like medical device inserted into the largest vein in the body to prevent blood clots from making their way to the heart and lungs. At least 27 deaths and hundreds of injuries have now been associated with the use of the IVC filter made by C.R. Bard, Inc. A number of IVC filter lawsuits have led to an investigation into how the C.R. Bard, Inc. Recovery IVC filter made it’s way onto the market in spite of serious safety concerns.
NBC News reports that the company hired a consultant to help get the Recovery IVC filter approved by the U.S. Food and Drug Administration after a failed initial attempt. The consultant explains she voiced concerns over the safety of the device and refused to sign the applications for the device to seek approval. Documents show the consultant’s signature on those documents, though.
At Ferrer, Poirot & Wansbrough, we believe in protecting the health and safety of medical patients, and our defective medical device lawyers are hopeful the discovery of C.R. Bard’s potentially negligent handling of the Recovery filter’s approval process can result in action towards creating accountability among medical device manufacturers.
September 29th, 2015
Warning labels on prescription medications educate consumers about risks a drug may pose. The problem is, many drug side effects aren’t discovered until after many consumers have been exposed to them.
Recently, a controversy erupted over allegations that warning labels on the antidepressant, Zoloft®, failed to inform female patients of the risk of congenital heart defects in children if the medication is taken during pregnancy.
Several Zoloft side effects studies showed that taking the drug while pregnant can lead to an increased risk of birth defects, such as persistent pulmonary hypertension or omphalocele.
The makers of Zoloft have maintained the drug is safe for pregnant women despite the findings.
An article from Bloomberg Business says the U.S. Food and Drug Administration has asked Pfizer, Inc., the drug’s manufacturer, to change the warning labels to address the risk of birth defects.
At Ferrer, Poirot & Wansbrough, our drug injury lawyers are hopeful changes are made to the warning labels on Zoloft to better protect patients and their families.
September 22nd, 2015
Antibiotics play a crucial role in the treatment of many serious infections, but many can have serious side effects. The Levaquin® injury lawyers at Ferrer, Poirot & Wansbrough think it’s important for you to know the risks associated with this drug in particular.
For years, federal regulators were aware of risks associated with using Levaquin. But because of the drug’s capability of warding off dangerous and serious infections, it remains on the market.
To reduce the number of patients who suffer side effects, the U.S. Food and Drug Administration updated the warning labels several times over the years. In 2004, warning labels advising patients of the risk of temporary peripheral nervous system damage were added to the drug’s packaging, Then, in 2013, a warning of permanent peripheral nervous system damage was added.
Now, some patients who have experienced Levaquin side effects are calling for another warning label to be added to drug packaging. ABC 2 News reports a petition is calling for a black box warning to be added to Levaquin that informs patients about the risks of developing a condition known as mitochondrial toxicity.
If you are taking Levaquin or another medication to ward off infection, it’s crucial that you’re aware of antibiotic side effects, as well as your rights as a patient. You can learn more about these topics by visiting our website.